These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 20660698)
1. Cellular immune responses to HCV core increase and HCV RNA levels decrease during successful antiretroviral therapy. Rohrbach J; Robinson N; Harcourt G; Hammond E; Gaudieri S; Gorgievski M; Telenti A; Keiser O; Günthard HF; Hirschel B; Hoffmann M; Bernasconi E; Battegay M; Furrer H; Klenerman P; Rauch A; Gut; 2010 Sep; 59(9):1252-8. PubMed ID: 20660698 [TBL] [Abstract][Full Text] [Related]
2. Fosamprenavir treatment in a highly active antiretroviral therapy schedule induces a HCV-RNA decrease and a Th1 network boost in HIV/HCV-coinfected patients. Perrella A; Sbreglia C; D'Antonio A; Atripaldi L; Perrella O Clin Microbiol Infect; 2010 Jun; 16(6):676-8. PubMed ID: 19681945 [TBL] [Abstract][Full Text] [Related]
3. Role of hepatitis C virus (HCV) viremia and HCV genotype in the immune recovery from highly active antiretroviral therapy in a cohort of antiretroviral-naive HIV-infected individuals. Antonucci G; Girardi E; Cozzi-Lepri A; Capobianchi MR; De Luca A; Puoti M; Petrelli E; Carnevale G; Rizzardini G; Grossi PA; Viganò P; Moioli MC; Carletti F; Solmone M; Ippolito G; Monforte AD; ; Clin Infect Dis; 2005 Jun; 40(12):e101-9. PubMed ID: 15909251 [TBL] [Abstract][Full Text] [Related]
4. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. Zeitoun JD; Mallet V; Chaix ML; Viard JP; Blanche S; Pol S J Clin Virol; 2007 Sep; 40(1):71-3. PubMed ID: 17658294 [TBL] [Abstract][Full Text] [Related]
5. [Chronic hepatitis C in patients with HIV/HCV coinfection with high CD4+ lymphocytes count]. Inglot M; Szymczak A; Gładysz A; Małyszczak K; Zalewska M Przegl Epidemiol; 2007; 61(3):535-43. PubMed ID: 18069391 [TBL] [Abstract][Full Text] [Related]
6. Case report: clearance of hepatitis C virus after changing the HAART regimen in a patient infected with hepatitis C virus and the human immunodeficiency virus. Endo T; Fujimoto K; Nishio M; Yamamoto S; Obara M; Sato N; Koike T J Med Virol; 2009 Jun; 81(6):979-82. PubMed ID: 19382259 [TBL] [Abstract][Full Text] [Related]
7. HIV and hepatitis C coinfection. Matthews GV; Dore GJ J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597 [TBL] [Abstract][Full Text] [Related]
8. Effect of hepatitis C infection on progression of HIV disease and early response to initial antiretroviral therapy. Sullivan PS; Hanson DL; Teshale EH; Wotring LL; Brooks JT AIDS; 2006 May; 20(8):1171-9. PubMed ID: 16691069 [TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus coinfection and HIV load, CD4+ cell percentage, and clinical progression to AIDS or death among HIV-infected women: Women and Infants Transmission Study. Hershow RC; O'Driscoll PT; Handelsman E; Pitt J; Hillyer G; Serchuck L; Lu M; Chen KT; Yawetz S; Pacheco S; Davenny K; Adeniyi-Jones S; Thomas DL Clin Infect Dis; 2005 Mar; 40(6):859-67. PubMed ID: 15736020 [TBL] [Abstract][Full Text] [Related]
10. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART? Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563 [TBL] [Abstract][Full Text] [Related]
11. Naive HIV/HCV-coinfected patients have higher intrahepatic pro-inflammatory cytokines than coinfected patients treated with antiretroviral therapy. Sitia G; De Bona A; Bagaglio S; Galli L; Paties CT; Uberti-Foppa C; Guidotti LG; Lazzarin A; Morsica G Antivir Ther; 2006; 11(3):385-9. PubMed ID: 16759056 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive longitudinal analysis of hepatitis C virus (HCV)-specific T cell responses during acute HCV infection in the presence of existing HIV-1 infection. van den Berg CH; Ruys TA; Nanlohy NM; Geerlings SE; van der Meer JT; Mulder JW; Lange JA; van Baarle D J Viral Hepat; 2009 Apr; 16(4):239-48. PubMed ID: 19222746 [TBL] [Abstract][Full Text] [Related]
13. Impact of highly active antiretroviral therapy on hepatitis C virus protease quasispecies diversity in HIV co-infected patients. Winters MA; Chary A; Eison R; Asmuth D; Holodniy M J Med Virol; 2010 May; 82(5):791-8. PubMed ID: 20336744 [TBL] [Abstract][Full Text] [Related]
14. Acute hepatitis C in HIV-infected patients: rare spontaneous clearance correlates with weak memory CD4 T-cell responses to hepatitis C virus. Schnuriger A; Dominguez S; Guiguet M; Harfouch S; Samri A; Ouazene Z; Slama L; Simon A; Valantin MA; Thibault V; Autran B; AIDS; 2009 Oct; 23(16):2079-89. PubMed ID: 19710595 [TBL] [Abstract][Full Text] [Related]
15. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir. Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639 [TBL] [Abstract][Full Text] [Related]
16. CD8+ cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. Alatrakchi N; Graham CS; He Q; Sherman KE; Koziel MJ J Infect Dis; 2005 Mar; 191(5):702-9. PubMed ID: 15688283 [TBL] [Abstract][Full Text] [Related]
17. Cryoglobulinaemia vasculitis in patients coinfected with HIV and hepatitis C virus. Saadoun D; Aaron L; Resche-Rigon M; Pialoux G; Piette JC; Cacoub P; AIDS; 2006 Apr; 20(6):871-7. PubMed ID: 16549971 [TBL] [Abstract][Full Text] [Related]
18. Clearance of hepatitis C virus in HIV-infected patients with multiple chronic viral hepatitis. Martín-Carbonero L; Barreiro P; Jiménez-Galán G; García-Berriguete R; Núñez M; Ríos P; González-Lahoz J; Soriano V J Viral Hepat; 2007 Jun; 14(6):392-5. PubMed ID: 17501759 [TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C viral load changes following initiation of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection. Asmuth DM; Busch MP; Laycock ME; Mohr BA; Kalish LA; van der Horst CM; Antiviral Res; 2004 Aug; 63(2):123-31. PubMed ID: 15302141 [TBL] [Abstract][Full Text] [Related]
20. Virus-specific T-cell responses associated with hepatitis C virus (HCV) persistence in the liver after apparent recovery from HCV infection. Quiroga JA; Llorente S; Castillo I; Rodríguez-Iñigo E; López-Alcorocho JM; Pardo M; Carreño V J Med Virol; 2006 Sep; 78(9):1190-7. PubMed ID: 16847959 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]